{"id":54221,"date":"2025-11-11T19:28:35","date_gmt":"2025-11-11T13:58:35","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=54221"},"modified":"2025-11-11T19:29:13","modified_gmt":"2025-11-11T13:59:13","slug":"astrazeneca-pharma-india-q2-results-2025","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-q2-results-2025\/","title":{"rendered":"Astrazeneca Pharma India Q2 Results 2025 Highlights: Net Profit Surged by 41.09% &#038; Revenue Up 37.03% YoY"},"content":{"rendered":"<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong><em>Click and Sign Up to Get Live Updates on Q2 Results&nbsp;<\/em><\/strong><\/a><\/p><p><strong>Astrazeneca Pharma India <em>Q2 Results FY26<\/em><\/strong>: During Q2 FY26,\u00a0 Astrazeneca Pharma India&#8217;s profit increased 41.09% YoY, while revenue increased by 37.03% YoY. The company posted robust numbers, with Q2 PAT at \u20b954.22 crores and revenue at \u20b9559.09 crores. <a href=\"https:\/\/univest.in\/stocks\/astrazen\/astrazeneca-pharma-india-ltd-share-price-today\">Astrazeneca Pharma India<\/a> showed its Q2 results on 7th November 2025.\u00a0\u00a0<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-q2-results-2025\/#Astrazeneca_Pharma_India_Q2_Results_FY26_Extracts_of_FY25_FY26\" title=\"Astrazeneca Pharma India Q2 Results FY26: Extracts of FY25 &amp; FY26\">Astrazeneca Pharma India Q2 Results FY26: Extracts of FY25 &amp; FY26<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-q2-results-2025\/#Astrazeneca_Pharma_India_Q2_Results_FY26_Highlights_Q2_FY26_vs_FY25\" title=\"Astrazeneca Pharma India Q2 Results FY26 Highlights (Q2 FY26 vs FY25)\">Astrazeneca Pharma India Q2 Results FY26 Highlights (Q2 FY26 vs FY25)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-q2-results-2025\/#Astrazeneca_Pharma_India_Share_Price_Performance\" title=\"Astrazeneca Pharma India Share Price Performance\u00a0\">Astrazeneca Pharma India Share Price Performance\u00a0<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-q2-results-2025\/#What_Analysts_Expect_Post_Q2_Results\" title=\"What Analysts Expect Post Q2 Results?\">What Analysts Expect Post Q2 Results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-q2-results-2025\/#Recent_Articles\" title=\"Recent Articles\">Recent Articles<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Astrazeneca_Pharma_India_Q2_Results_FY26_Extracts_of_FY25_FY26\"><\/span><strong>Astrazeneca Pharma India Q2 Results FY26: Extracts of FY25 &amp; FY26<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Particulars<\/strong><\/td><td colspan=\"2\"><strong>Standalone Figures<\/strong><\/td><\/tr><tr><td><\/td><td><strong>30th Sept 2025<\/strong><\/td><td><strong>30th Sept 2024<\/strong><\/td><\/tr><tr><td><strong>Revenue from Operations<\/strong><\/td><td>\u20b9559.09<\/td><td>\u20b9408.00<\/td><\/tr><tr><td><strong>Profit Before Tax (PBT)<\/strong><\/td><td>\u20b981.35<\/td><td>\u20b960.69<\/td><\/tr><tr><td><strong>Profit After Tax (PAT)<\/strong><\/td><td>\u20b954.22<\/td><td>\u20b938.43<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Astrazeneca_Pharma_India_Q2_Results_FY26_Highlights_Q2_FY26_vs_FY25\"><\/span><strong>Astrazeneca Pharma India Q2 Results FY26 Highlights (Q2 FY26 vs FY25)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><ul class=\"wp-block-list\"><li>Astrazeneca Pharma India clocked Q2 FY26 standalone revenue of \u20b9559.09 crores vs \u20b9408.00 crores.\u00a0<\/li>\n\n<li>On the profit front,\u00a0 Astrazeneca Pharma India earned a standalone PAT of \u20b954.22 crore in Q2 FY26. During FY25, the company\u2019s PAT stood at \u20b938.43 crore.<\/li>\n\n<li>According to the standalone figures,\u00a0 Astrazeneca Pharma India&#8217;s quarterly PAT increased by 41.09% YoY, while revenue increased by 37.03%.<\/li><\/ul><p><strong><em>Download the <\/em><\/strong><a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\"><strong><em>Univest iOS App<\/em><\/strong><\/a><strong><em> or <\/em><\/strong><a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\"><strong><em>Univest Android App<\/em><\/strong><\/a><strong><em> to get daily stock recommendations and insightful research pieces!<\/em><\/strong>&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Astrazeneca_Pharma_India_Share_Price_Performance\"><\/span><strong>Astrazeneca Pharma India Share Price Performance\u00a0<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>On the opening bell on 11th November 2025,&nbsp; Astrazeneca Pharma India shares opened at \u20b99,042.00 per share. However, the initial gains have since eroded, and Astrazeneca Pharma India shares are currently trading at \u20b99,150.00 per share, which is higher than the opening price.&nbsp;&nbsp;&nbsp;&nbsp;<\/p><p>Considering the long-term achievements, Astrazeneca Pharma India shares have yielded returns of approximately 14.80% over the past 6 months, and 1-year returns stand at 24.49%. Over the maximum timeframe, Astrazeneca Pharma India shares delivered a 12,823.73% return to investors.&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Analysts_Expect_Post_Q2_Results\"><\/span><strong>What Analysts Expect Post Q2 Results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Following Astrazeneca Pharma India&#8217;s robust Q2 results for FY26, analysts expect its share price to rise. According to analysts, Kalyan Jewellers&#8217; share price in India is expected to reach \u20b99,500.00 per share in the coming year, and in a downturn, it could fall to \u20b99,000.00 per share. However, one must ignore stock market volatility and invest in&nbsp; Astrazeneca Pharma India shares after thorough research.&nbsp;<\/p><p><strong><em>Disclaimer:<\/em><\/strong><em> Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.<\/em><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Articles\"><\/span><strong>Recent Articles<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/nestle-q2-results-2025\">Nestle Q2 Results FY26: Q2 PAT Falls 17.38% to \u20b9743.17 Crore; Revenue Up 10.57% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/inspira-enterprise-india-ipo-details\">Inspira Enterprise India IPO Details: Everything You Should Know about<\/a>&nbsp;<\/p><p><a href=\"https:\/\/univest.in\/blogs\/swaraj-engines-q2-results-fy26\">Swaraj Engines Q2 Results FY26: Q2 PAT Rises 8.88% to \u20b949 Crore; Revenue Up 8.62% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/hdb-financial-q2-results-2025\">HDB Financial Q2 Results FY26: Q2 PAT Falls 1.5% to \u20b9581 Crore; Revenue Up 13.42% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/bel-gears-q2-results-expectations\">BEL Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/paytm-q2-results-expectations\">Paytm Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/blue-dart-q2-results-expectations\">Blue Dart Gears Up for Q2 Reveal on 28th October; Check Key Expectations Here<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Click and Sign Up to Get Live Updates on Q2 Results&nbsp; Astrazeneca Pharma India Q2 Results FY26: During Q2 FY26,\u00a0 Astrazeneca Pharma India&#8217;s profit increased 41.09% YoY, while revenue increased by 37.03% YoY. The company posted robust numbers, with Q2 PAT at \u20b954.22 crores and revenue at \u20b9559.09 crores. Astrazeneca Pharma India showed its Q2<\/p>\n","protected":false},"author":23,"featured_media":54222,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3295],"class_list":["post-54221","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-astrazeneca-pharma-india-q2-results-2025"],"metadata":{"_edit_lock":["1762869553:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"rank_math_primary_category":["842"],"rank_math_seo_score":["77"],"rank_math_title":["Astrazeneca Pharma India Q2 Results 2025: Net Profit Surged 41.09% YoY"],"rank_math_description":["Discover the recent updates on Astrazeneca Pharma India Q2 results for FY26. Q2 profit rose 41.09% YoY to \u20b954.22 crore, and revenue increased by 37.03% YoY. Learn more about the company's financials.\r\n"],"rank_math_focus_keyword":["Astrazeneca Pharma India Q2 Results"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["54222"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["4533"],"_wp_page_template":["default"],"rs_page_bg_color":[""],"rank_math_canonical_url":["https:\/\/univest.in\/blogs\/astrazeneca-pharma-india-q2-results-2025"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/11192547\/Astrazeneca-Pharma-India-Q2-Results-2025-Net-Profit-Surged-41.09-YoY.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/54221","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=54221"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/54221\/revisions"}],"predecessor-version":[{"id":54223,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/54221\/revisions\/54223"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/54222"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=54221"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=54221"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=54221"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}